Home / All Categories / Medical Care / Global Primary Sclerosing Cholangitis Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Global Primary Sclerosing Cholangitis Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Global Primary Sclerosing Cholangitis Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Pages: 118      Published Date: Mar 2019       Category: Medical Care
Primary sclerosing cholangitis (PSC) is a condition causing long-term inflammation and scarring (fibrosis) of bile ducts in the liver. These ducts are tubes that allow the liquid (bile) produced by the liver to pass through the intestine allowing fat digestion. This disease predominantly affects men between the age of 25 and 40 years. The damage to the ducts causes accumulation of bile acids, essential components of bile to build up in the liver leading to liver tissue damage, portal hypertension (high blood pressure in the vessels connecting the liver and the gut), and liver failure, and may increase the risk of liver cancer.

Scope of the Report:
Requirement of providing affordable treatment, owing to high costs associated with liver transplantation coupled with increasing risk factors resulting in the development of serious disorders are major factors that are expected to increase the adoption of PSC drugs, in turn favoring market growth in the near future.
The global Primary Sclerosing Cholangitis market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Primary Sclerosing Cholangitis.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Primary Sclerosing Cholangitis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Primary Sclerosing Cholangitis market by product type and applications/end industries.

Market Segment by Companies, this report covers
    Acorda Therapeutics, Inc.
    Gilead Sciences, Inc.
    Intercept Pharmaceuticals, Inc.
    Shire Plc.
    NGM Biopharmaceuticals, Inc.
    Dr. Falk Pharma GmbH
    Allergan Plc.
    Conatus Pharmaceuticals, Inc.
    Durect Corporation
    Sirnaomics, Inc.
    Shenzhen HighTide Biopharmaceuticals Ltd.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
    Type I
    Type II

Market Segment by Applications, can be divided into
    Hospital
    Clinics
    Other
Table of Contents

1 Primary Sclerosing Cholangitis Market Overview
    1.1 Product Overview and Scope of Primary Sclerosing Cholangitis
    1.2 Classification of Primary Sclerosing Cholangitis by Types
        1.2.1 Global Primary Sclerosing Cholangitis Revenue Comparison by Types (2019-2024)
        1.2.2 Global Primary Sclerosing Cholangitis Revenue Market Share by Types in 2018
        1.2.3 Type I
        1.2.4 Type II
    1.3 Global Primary Sclerosing Cholangitis Market by Application
        1.3.1 Global Primary Sclerosing Cholangitis Market Size and Market Share Comparison by Applications (2014-2024)
        1.3.2 Hospital
        1.3.3 Clinics
        1.3.4 Other
    1.4 Global Primary Sclerosing Cholangitis Market by Regions
        1.4.1 Global Primary Sclerosing Cholangitis Market Size (Million USD) Comparison by Regions (2014-2024)
        1.4.1 North America (USA, Canada and Mexico) Primary Sclerosing Cholangitis Status and Prospect (2014-2024)
        1.4.2 Europe (Germany, France, UK, Russia and Italy) Primary Sclerosing Cholangitis Status and Prospect (2014-2024)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Primary Sclerosing Cholangitis Status and Prospect (2014-2024)
        1.4.4 South America (Brazil, Argentina, Colombia) Primary Sclerosing Cholangitis Status and Prospect (2014-2024)
        1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Primary Sclerosing Cholangitis Status and Prospect (2014-2024)
    1.5 Global Market Size of Primary Sclerosing Cholangitis (2014-2024)
2 Manufacturers Profiles
    2.1 Acorda Therapeutics, Inc.
        2.1.1 Business Overview
        2.1.2 Primary Sclerosing Cholangitis Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 Acorda Therapeutics, Inc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
    2.2 Gilead Sciences, Inc.
        2.2.1 Business Overview
        2.2.2 Primary Sclerosing Cholangitis Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Gilead Sciences, Inc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
    2.3 Intercept Pharmaceuticals, Inc.
        2.3.1 Business Overview
        2.3.2 Primary Sclerosing Cholangitis Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 Intercept Pharmaceuticals, Inc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
    2.4 Shire Plc.
        2.4.1 Business Overview
        2.4.2 Primary Sclerosing Cholangitis Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Shire Plc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
    2.5 NGM Biopharmaceuticals, Inc.
        2.5.1 Business Overview
        2.5.2 Primary Sclerosing Cholangitis Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 NGM Biopharmaceuticals, Inc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
    2.6 Dr. Falk Pharma GmbH
        2.6.1 Business Overview
        2.6.2 Primary Sclerosing Cholangitis Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 Dr. Falk Pharma GmbH Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
    2.7 Allergan Plc.
        2.7.1 Business Overview
        2.7.2 Primary Sclerosing Cholangitis Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Allergan Plc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
    2.8 Conatus Pharmaceuticals, Inc.
        2.8.1 Business Overview
        2.8.2 Primary Sclerosing Cholangitis Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 Conatus Pharmaceuticals, Inc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
    2.9 Durect Corporation
        2.9.1 Business Overview
        2.9.2 Primary Sclerosing Cholangitis Type and Applications
            2.9.2.1 Product A
            2.9.2.2 Product B
        2.9.3 Durect Corporation Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
    2.10 Sirnaomics, Inc.
        2.10.1 Business Overview
        2.10.2 Primary Sclerosing Cholangitis Type and Applications
            2.10.2.1 Product A
            2.10.2.2 Product B
        2.10.3 Sirnaomics, Inc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
    2.11 Shenzhen HighTide Biopharmaceuticals Ltd.
        2.11.1 Business Overview
        2.11.2 Primary Sclerosing Cholangitis Type and Applications
            2.11.2.1 Product A
            2.11.2.2 Product B
        2.11.3 Shenzhen HighTide Biopharmaceuticals Ltd. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
3 Global Primary Sclerosing Cholangitis Market Competition, by Players
    3.1 Global Primary Sclerosing Cholangitis Revenue and Share by Players (2014-2019)
    3.2 Market Concentration Rate
        3.2.1 Top 5 Primary Sclerosing Cholangitis Players Market Share
        3.2.2 Top 10 Primary Sclerosing Cholangitis Players Market Share
    3.3 Market Competition Trend
4 Global Primary Sclerosing Cholangitis Market Size by Regions
    4.1 Global Primary Sclerosing Cholangitis Revenue and Market Share by Regions
    4.2 North America Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    4.3 Europe Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    4.4 Asia-Pacific Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    4.5 South America Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    4.6 Middle East and Africa Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
5 North America Primary Sclerosing Cholangitis Revenue by Countries
    5.1 North America Primary Sclerosing Cholangitis Revenue by Countries (2014-2019)
    5.2 USA Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    5.3 Canada Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    5.4 Mexico Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
6 Europe Primary Sclerosing Cholangitis Revenue by Countries
    6.1 Europe Primary Sclerosing Cholangitis Revenue by Countries (2014-2019)
    6.2 Germany Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    6.3 UK Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    6.4 France Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    6.5 Russia Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    6.6 Italy Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Primary Sclerosing Cholangitis Revenue by Countries
    7.1 Asia-Pacific Primary Sclerosing Cholangitis Revenue by Countries (2014-2019)
    7.2 China Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    7.3 Japan Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    7.4 Korea Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    7.5 India Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    7.6 Southeast Asia Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
8 South America Primary Sclerosing Cholangitis Revenue by Countries
    8.1 South America Primary Sclerosing Cholangitis Revenue by Countries (2014-2019)
    8.2 Brazil Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    8.3 Argentina Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    8.4 Colombia Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Primary Sclerosing Cholangitis by Countries
    9.1 Middle East and Africa Primary Sclerosing Cholangitis Revenue by Countries (2014-2019)
    9.2 Saudi Arabia Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    9.3 UAE Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    9.4 Egypt Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    9.5 Nigeria Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
    9.6 South Africa Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
10 Global Primary Sclerosing Cholangitis Market Segment by Type
    10.1 Global Primary Sclerosing Cholangitis Revenue and Market Share by Type (2014-2019)
    10.2 Global Primary Sclerosing Cholangitis Market Forecast by Type (2019-2024)
    10.3 Type I Revenue Growth Rate (2014-2024)
    10.4 Type II Revenue Growth Rate (2014-2024)
11 Global Primary Sclerosing Cholangitis Market Segment by Application
    11.1 Global Primary Sclerosing Cholangitis Revenue Market Share by Application (2014-2019)
    11.2 Primary Sclerosing Cholangitis Market Forecast by Application (2019-2024)
    11.3 Hospital Revenue Growth (2014-2019)
    11.4 Clinics Revenue Growth (2014-2019)
    11.5 Other Revenue Growth (2014-2019)
12 Global Primary Sclerosing Cholangitis Market Size Forecast (2019-2024)
    12.1 Global Primary Sclerosing Cholangitis Market Size Forecast (2019-2024)
    12.2 Global Primary Sclerosing Cholangitis Market Forecast by Regions (2019-2024)
    12.3 North America Primary Sclerosing Cholangitis Revenue Market Forecast (2019-2024)
    12.4 Europe Primary Sclerosing Cholangitis Revenue Market Forecast (2019-2024)
    12.5 Asia-Pacific Primary Sclerosing Cholangitis Revenue Market Forecast (2019-2024)
    12.6 South America Primary Sclerosing Cholangitis Revenue Market Forecast (2019-2024)
    12.7 Middle East and Africa Primary Sclerosing Cholangitis Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Data Source
List of Tables and Figures

Figure Primary Sclerosing Cholangitis Picture
Table Product Specifications of Primary Sclerosing Cholangitis
Table Global Primary Sclerosing Cholangitis and Revenue (Million USD) Market Split by Product Type
Figure Global Primary Sclerosing Cholangitis Revenue Market Share by Types in 2018
Figure Type I Picture
Figure Type II Picture
Table Global Primary Sclerosing Cholangitis Revenue (Million USD) by Application (2014-2024)
Figure Primary Sclerosing Cholangitis Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinics Picture
Figure Other Picture
Table Global Market Primary Sclerosing Cholangitis Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Primary Sclerosing Cholangitis Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Primary Sclerosing Cholangitis Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Primary Sclerosing Cholangitis Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Primary Sclerosing Cholangitis Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Primary Sclerosing Cholangitis Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Primary Sclerosing Cholangitis Revenue (Million USD) and Growth Rate (2014-2024)
Table Acorda Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table Acorda Therapeutics, Inc. Primary Sclerosing Cholangitis Type and Applications
Table Acorda Therapeutics, Inc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences, Inc. Primary Sclerosing Cholangitis Type and Applications
Table Gilead Sciences, Inc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
Table Intercept Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table Intercept Pharmaceuticals, Inc. Primary Sclerosing Cholangitis Type and Applications
Table Intercept Pharmaceuticals, Inc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
Table Shire Plc. Basic Information, Manufacturing Base and Competitors
Table Shire Plc. Primary Sclerosing Cholangitis Type and Applications
Table Shire Plc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
Table NGM Biopharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table NGM Biopharmaceuticals, Inc. Primary Sclerosing Cholangitis Type and Applications
Table NGM Biopharmaceuticals, Inc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
Table Dr. Falk Pharma GmbH Basic Information, Manufacturing Base and Competitors
Table Dr. Falk Pharma GmbH Primary Sclerosing Cholangitis Type and Applications
Table Dr. Falk Pharma GmbH Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Plc. Basic Information, Manufacturing Base and Competitors
Table Allergan Plc. Primary Sclerosing Cholangitis Type and Applications
Table Allergan Plc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
Table Conatus Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table Conatus Pharmaceuticals, Inc. Primary Sclerosing Cholangitis Type and Applications
Table Conatus Pharmaceuticals, Inc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
Table Durect Corporation Basic Information, Manufacturing Base and Competitors
Table Durect Corporation Primary Sclerosing Cholangitis Type and Applications
Table Durect Corporation Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
Table Sirnaomics, Inc. Basic Information, Manufacturing Base and Competitors
Table Sirnaomics, Inc. Primary Sclerosing Cholangitis Type and Applications
Table Sirnaomics, Inc. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
Table Shenzhen HighTide Biopharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table Shenzhen HighTide Biopharmaceuticals Ltd. Primary Sclerosing Cholangitis Type and Applications
Table Shenzhen HighTide Biopharmaceuticals Ltd. Primary Sclerosing Cholangitis Revenue, Gross Margin and Market Share (2017-2018)
Table Global Primary Sclerosing Cholangitis Revenue (Million USD) by Players (2014-2019)
Table Global Primary Sclerosing Cholangitis Revenue Share by Players (2014-2019)
Figure Global Primary Sclerosing Cholangitis Revenue Share by Players in 2017
Figure Global Primary Sclerosing Cholangitis Revenue Share by Players in 2018
Figure Global Top 5 Players Primary Sclerosing Cholangitis Revenue Market Share in 2018
Figure Global Top 10 Players Primary Sclerosing Cholangitis Revenue Market Share in 2018
Figure Global Primary Sclerosing Cholangitis Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Primary Sclerosing Cholangitis Revenue (Million USD) by Regions (2014-2019)
Table Global Primary Sclerosing Cholangitis Revenue Market Share by Regions (2014-2019)
Figure Global Primary Sclerosing Cholangitis Revenue Market Share by Regions (2014-2019)
Figure Global Primary Sclerosing Cholangitis Revenue Market Share by Regions in 2018
Figure North America Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure Europe Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure South America Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Table North America Primary Sclerosing Cholangitis Revenue by Countries (2014-2019)
Table North America Primary Sclerosing Cholangitis Revenue Market Share by Countries (2014-2019)
Figure North America Primary Sclerosing Cholangitis Revenue Market Share by Countries (2014-2019)
Figure North America Primary Sclerosing Cholangitis Revenue Market Share by Countries in 2018
Figure USA Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure Canada Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure Mexico Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Table Europe Primary Sclerosing Cholangitis Revenue (Million USD) by Countries (2014-2019)
Figure Europe Primary Sclerosing Cholangitis Revenue Market Share by Countries (2014-2019)
Figure Europe Primary Sclerosing Cholangitis Revenue Market Share by Countries in 2018
Figure Germany Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure UK Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure France Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure Russia Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure Italy Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Primary Sclerosing Cholangitis Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Primary Sclerosing Cholangitis Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Primary Sclerosing Cholangitis Revenue Market Share by Countries in 2018
Figure China Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure Japan Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure Korea Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure India Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Table South America Primary Sclerosing Cholangitis Revenue by Countries (2014-2019)
Table South America Primary Sclerosing Cholangitis Revenue Market Share by Countries (2014-2019)
Figure South America Primary Sclerosing Cholangitis Revenue Market Share by Countries (2014-2019)
Figure South America Primary Sclerosing Cholangitis Revenue Market Share by Countries in 2018
Figure Brazil Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure Argentina Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure Colombia Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Primary Sclerosing Cholangitis Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Primary Sclerosing Cholangitis Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Primary Sclerosing Cholangitis Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Primary Sclerosing Cholangitis Revenue Market Share by Countries in 2018
Figure Saudi Arabia Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure UAE Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure Egypt Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure Nigeria Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Figure South Africa Primary Sclerosing Cholangitis Revenue and Growth Rate (2014-2019)
Table Global Primary Sclerosing Cholangitis Revenue (Million USD) by Type (2014-2019)
Table Global Primary Sclerosing Cholangitis Revenue Share by Type (2014-2019)
Figure Global Primary Sclerosing Cholangitis Revenue Share by Type (2014-2019)
Figure Global Primary Sclerosing Cholangitis Revenue Share by Type in 2019
Table Global Primary Sclerosing Cholangitis Revenue Forecast by Type (2019-2024)
Figure Global Primary Sclerosing Cholangitis Market Share Forecast by Type (2019-2024)
Figure Global Type I Revenue Growth Rate (2014-2019)
Figure Global Type II Revenue Growth Rate (2014-2019)
Table Global Primary Sclerosing Cholangitis Revenue by Application (2014-2019)
Table Global Primary Sclerosing Cholangitis Revenue Share by Application (2014-2019)
Figure Global Primary Sclerosing Cholangitis Revenue Share by Application (2014-2019)
Figure Global Primary Sclerosing Cholangitis Revenue Share by Application in 2019
Table Global Primary Sclerosing Cholangitis Revenue Forecast by Application (2019-2024)
Figure Global Primary Sclerosing Cholangitis Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Primary Sclerosing Cholangitis Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Primary Sclerosing Cholangitis Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Primary Sclerosing Cholangitis Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Primary Sclerosing Cholangitis Revenue Market Forecast (2019-2024)
Figure Europe Primary Sclerosing Cholangitis Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Primary Sclerosing Cholangitis Revenue Market Forecast (2019-2024)
Figure South America Primary Sclerosing Cholangitis Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Primary Sclerosing Cholangitis Revenue Market Forecast (2019-2024)
Acorda Therapeutics, Inc.
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.
Shire Plc.
NGM Biopharmaceuticals, Inc.
Dr. Falk Pharma GmbH
Allergan Plc.
Conatus Pharmaceuticals, Inc.
Durect Corporation
Sirnaomics, Inc.
Shenzhen HighTide Biopharmaceuticals Ltd.
Request Sample
If you need any reports sample, just let us know
Full Name: *
Email Address: *
Country: *
Phone Number: *
Channel: *
Other:
Request Message: *
Verification Code: *
 
We aim to respond to all request on the same business day.

Purchase this Market Research Report

Single User License 3480.00 USD
Multi User License 5220.00 USD
Corporate Users License 6960.00 USD
Add to Cart Buy Now
goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico